VTRS

#547
Viatris Inc. Common Stock
14.9300
-4.14%
Secteur:
Base:
Devise de Profit:
Range quotidien
14.9300
14.9300
Range Annuel
9.9200
16.4700
Changement quotidien
-4.14%
Changement Mensuel
+13.54%
Evolution sur 6 mois
+44.25%
Changement Annuel
+44.25%
Clôture Précédente
15.5750
Open
14.9300
Bid
Ask
Low
14.9300
High
14.9300
Volume
342
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 17.3875 B
  • Employee 30 K
  • Founded 2020
  • CEO Scott A. Smith
  • Website www.viatris.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y4RQNH4
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.15
Price to sales ratio
—
Dividends per share
0.12
Dividend yield %
3.86

Viatris Inc

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue.

Nouvelles